Based on these findings, we next crossed Evi1 heterozygous knock-out (Evi1+/−) mice with BCR–ABLtg/− mice to clarify whether loss of Evi1 would affect CML development (Figure 3f). The gene discussed is MECOM; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.